Tenzing Acquisition Corp. | Business Contracts

Placement Agency Agreement, dated September 6, 2022, by and between the Company and the Placement Agent (Filed With SEC on September 7, 2022)

Formof Securities Purchase Agreement, dated September 6, 2022, by and between the Company and the Private Placement Entities (Filed With SEC on September 7, 2022)

Employment Letter, dated as of April 14, 2021, by and between Marc Cantillon and Reviva Pharmaceuticals Holdings, Inc (Filed With SEC on April 15, 2021)

Description of Securities (Filed With SEC on March 22, 2021)

Agreement and Plan of Merger, dated as of July 20, 2020, by and among Tenzing, Merger Sub, Sponsor in the capacity as the Purchaser Representative, Reviva, and Dr. Bhat in the... (Filed With SEC on July 24, 2020)

Formof Securities Purchase Agreement, dated September 6, 2022, by and between the Company and the Institutional Investor (Filed With SEC on September 7, 2022)

Form of Private Placement Warrant (Filed With SEC on September 7, 2022)

Formof Private Pre-Funded Warrant (Filed With SEC on September 7, 2022)

Warrant Agency Agreement, dated as of June 1, 2021,by and between the Company and Continental Stock Transfer & Trust Company (Filed With SEC on August 16, 2021)

Form of Pre-Funded Warrant (Filed With SEC on August 16, 2021)

Form of Investor Warrant (Filed With SEC on August 16, 2021)

Form of Investor Warrant (Filed With SEC on May 25, 2021)

Form of Underwriting Agreement (Filed With SEC on May 25, 2021)

Form of Investor Warrant Agency Agreement between the Company and Continental Stock Transfer & Trust Company (Filed With SEC on May 25, 2021)

Form of Pre-Funded Warrant (Filed With SEC on May 25, 2021)

Form of Underwriting Agreement (Filed With SEC on May 10, 2021)

Form of Incentive Stock Option Grant Agreement (Filed With SEC on December 18, 2020)

Escrow Agreement, dated as of December 14, 2020, by and among the Company, Tenzing LLC, Laxminarayan Bhat and Continental Stock Transfer & Trust Company (Filed With SEC on December 18, 2020)

Letter Agreement, dated as of December 14, 2020, by and between the Company, Maxim Group LLC and Maxim Partners LLC (Filed With SEC on December 18, 2020)

Form of Note Purchase Agreement, dated as of August 29, 2020, by and between the Company and the investors party thereto (Filed With SEC on December 18, 2020)

Form of Note Purchase Agreement, dated as of August 27, 2020, by and between the Company and the investors party thereto (Filed With SEC on December 18, 2020)

Form of Assumed Option (Filed With SEC on December 18, 2020)

First Amendment to Reviva Pharmaceuticals, Inc. 2006 Equity Incentive Plan (Filed With SEC on December 18, 2020)

Reviva Pharmaceuticals, Inc. 2006 Equity Incentive Plan (Filed With SEC on December 18, 2020)

Form of Nonqualified Stock Option Grant Agreement (Filed With SEC on December 18, 2020)

Reviva Pharmaceuticals Holdings, Inc. 2020 Equity Incentive Plan (Filed With SEC on December 18, 2020)

Form of Assumed Warrant (Filed With SEC on December 18, 2020)

Form of Non-Redemption Agreement, dated as of December 8, 2020, by and among the Company, Tenzing LLC and the shareholder party thereto (Filed With SEC on December 18, 2020)

Saxena Indemnification Agreement (Filed With SEC on December 18, 2020)

Form of Indemnification Agreement (Filed With SEC on December 18, 2020)

Letter Agreement, dated as of March 15, 2016, by and between Marc Cantillon, MD and Reviva Pharmaceuticals, Inc (Filed With SEC on December 18, 2020)

Letter Agreement, dated as of October 28, 2015, by and between Marc Cantillon, MD and Reviva Pharmaceuticals, Inc (Filed With SEC on December 18, 2020)

Offer of Employment, dated as of December 12, 2012, by and between Marc Cantillon, MD and Reviva Pharmaceuticals, Inc (Filed With SEC on December 18, 2020)

Employment Agreement, dated as of December 14, 2020, by and between the Company and Dr. Bhat (Filed With SEC on December 18, 2020)

Form of Registration Rights Agreement, dated as of December 14, 2020, by and between the Company and the shareholder party thereto (Filed With SEC on December 18, 2020)

Promissory Note, dated November 12, 2020, issued by Tenzing Acquisition Corp. to Tenzing LLC (Filed With SEC on November 13, 2020)

Form of Waiver Letter, by Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. for the benefit of the Investor named therein (Filed With SEC on October 27, 2020)

Form of Backstop Agreement, by and among Tenzing Acquisition Corp., Reviva Pharmaceuticals, Inc., and the Investor named therein (Filed With SEC on October 22, 2020)

Promissory Note, dated September 24, 2020, issued by Tenzing Acquisition Corp. to Tenzing LLC (Filed With SEC on September 25, 2020)

Promissory Note, dated August 18, 2020, issued by Tenzing Acquisition Corp. to Tenzing LLC (Filed With SEC on August 18, 2020)

Promissory Note, dated July 24, 2020, issued by Tenzing Acquisition Corp. to Tenzing LLC (Filed With SEC on July 29, 2020)

Lock-Up Agreement, dated as of July 20, 2020 by and among Dr. Bhat, Tenzing and the Purchaser Representative (Filed With SEC on July 24, 2020)

Voting Agreement, dated as of July 20, 2020, by and among Dr. Bhat, Tenzing and Reviva (Filed With SEC on July 24, 2020)

Form of Lock-Up Agreement (General) (Filed With SEC on July 24, 2020)

Non-Competition Agreement, dated as of July 20, 2020 by Dr. Bhat in favor of Tenzing, Reviva and their respective affiliates (Filed With SEC on July 24, 2020)

Form of Bhat Employment Agreement (Filed With SEC on July 24, 2020)

Promissory Note, dated May 21, 2020, issued by Tenzing Acquisition Corp. to Tenzing LLC (Filed With SEC on May 21, 2020)

Description of the Registrants securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on May 4, 2020)

Promissory Note, dated February 10, 2020, issued by Tenzing Acquisition Corp. to Tenzing LLC (Filed With SEC on February 14, 2020)

Tenzing Acquisition Corp. (49)